申请人:Hoechst Aktiengesellschaft
公开号:US05571842A1
公开(公告)日:1996-11-05
Perfluoroalkyl-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them A description is given of perfluoroalkyl-substituted benzoylguanidines of the formula I ##STR1## where R(1) is (C.sub.1 -C.sub.6)-perfluoroalkyl-SO.sub.m ; R(2) and R(3) are H, halogen, alk(yl)(oxy), phenoxy; R(4) and R(5) are H, alkyl, Hal, CN, OR(7), NR(8)R(9), --(CH.sub.2).sub.n --(CF.sub.2).sub.o --CF.sub.3 and of the pharmacologically acceptable salts thereof; the compounds I are obtained by reacting a compound II ##STR2## with guanidine, L being a leaving group which is able readily to undergo nucleophilic substitution.
全氟烷基取代的苯甲酰胍啉,其制备过程,作为药物或诊断剂的用途,以及含有它们的药物。描述了公式I的全氟烷基取代苯甲酰胍啉##STR1##其中R(1)为(C.sub.1 -C.sub.6)-全氟烷基-SO.sub.m;R(2)和R(3)为H,卤素,烷基(氧基),苯氧基;R(4)和R(5)为H,烷基,卤素,CN,OR(7),NR(8)R(9),--(CH.sub.2).sub.n --(CF.sub.2).sub.o --CF.sub.3及其药理学上可接受的盐;化合物I通过将化合物II##STR2##与胍啉反应而得到,其中L是一种能够轻易发生亲核取代的脱离基。